DADC
DXCM icon

D.A. Davidson & Co’s DexCom DXCM Stock Holding History

D.A. Davidson & Co’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.75M Sell
27,800
-776
-3% -$54K 0.01% 740
2025
Q4 		$1.9M Sell
28,576
-3,417
-11% -$221K 0.01% 674
2025
Q3 		$2.15M Buy
31,993
+2,566
+9% +$203K 0.01% 622
2025
Q2 		$2.57M Buy
29,427
+3,315
+13% +$260K 0.02% 535
2025
Q1 		$1.78M Buy
26,112
+1,323
+5% +$108K 0.01% 601
2024
Q4 		$1.93M Sell
24,789
-7,789
-24% -$577K 0.02% 574
2024
Q3 		$2.18M Buy
32,578
+5,969
+22% +$490K 0.02% 523
2024
Q2 		$3.02M Sell
26,609
-8,876
-25% -$1.12M 0.03% 425
2024
Q1 		$4.92M Buy
35,485
+10
+0% +$1.26K 0.04% 302
2023
Q4 		$4.4M Buy
35,475
+465
+1% +$47.5K 0.04% 308
2023
Q3 		$3.27M Buy
35,010
+9,432
+37% +$1.06M 0.04% 346
2023
Q2 		$3.29M Sell
25,578
-4,641
-15% -$561K 0.03% 357
2023
Q1 		$3.51M Buy
30,219
+125
+0.4% +$14K 0.04% 328
2022
Q4 		$3.41M Sell
30,094
-2,276
-7% -$250K 0.04% 318
2022
Q3 		$2.61M Sell
32,370
-1,292
-4% -$109K 0.03% 356
2022
Q2 		$2.51M Buy
33,662
+2,038
+6% +$186K 0.03% 372
2022
Q1 		$4.04M Sell
31,624
-748
-2% -$81.8K 0.04% 298
2021
Q4 		$4.35M Buy
32,372
+172
+0.5% +$24.7K 0.05% 294
2021
Q3 		$4.4M Sell
32,200
-1,260
-4% -$159K 0.05% 277
2021
Q2 		$3.57M Buy
33,460
+3,100
+10% +$298K 0.04% 314
2021
Q1 		$2.73M Buy
30,360
+23,616
+350% +$2.22M 0.03% 336
2020
Q4 		$623K Buy
6,744
+1,668
+33% +$149K 0.01% 633
2020
Q3 		$523K Buy
5,076
+408
+9% +$42.6K 0.01% 599
2020
Q2 		$473K Sell
4,668
-16,252
-78% -$1.45M 0.01% 614
2020
Q1 		$1.41M Buy
20,920
+3,344
+19% +$208K 0.03% 390
2019
Q4 		$961K Sell
17,576
-2,512
-13% -$119K 0.02% 513
2019
Q3 		$749K Sell
20,088
-180
-0.9% -$6.99K 0.01% 547
2019
Q2 		$759K Buy
20,268
+800
+4% +$25.1K 0.01% 533
2019
Q1 		$580K Sell
19,468
-3,100
-14% -$109K 0.01% 645
2018
Q4 		$676K Buy
22,568
+8,444
+60% +$268K 0.01% 568
2018
Q3 		$505K Sell
14,124
-796
-5% -$24.7K 0.01% 708
2018
Q2 		$354K Buy
14,920
+200
+1% +$4.24K 0.01% 826
2018
Q1 		$273K Buy
14,720
+200
+1% +$2.96K 0.01% 889
2017
Q4 		$208K Buy
+14,520
New +$189K ﹤0.01% 994
2017
Q3 		– Sell
-13,000
Closed -$237K – 1305
2017
Q2 		$237K Sell
13,000
-340
-3% -$6.28K 0.01% 894
2017
Q1 		$282K Buy
13,340
+2,800
+27% +$54.7K 0.01% 806
2016
Q4 		$157K Hold
10,540
– – ﹤0.01% 1103
2016
Q3 		$230K Sell
10,540
-3,932
-27% -$87.5K 0.01% 892
2016
Q2 		$287K Buy
14,472
+10,920
+307% +$186K 0.01% 724
2016
Q1 		$60K Buy
3,552
+2,000
+129% +$33.4K ﹤0.01% 1323
2015
Q4 		$31K Buy
1,552
+1,132
+270% +$23.6K ﹤0.01% 1569
2015
Q3 		$9K Buy
420
+208
+98% +$4.64K ﹤0.01% 1876
2015
Q2 		$4K Buy
+212
New +$3.72K ﹤0.01% 2030

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

D.A. Davidson & Co's DXCM Position: Q1 2026 in Review

D.A. Davidson & Co reduced its DexCom (DXCM) stake by 2.7% in Q1 2026, selling an estimated $54K and leaving 27,800 shares worth $1.75M. The position accounts for 0.01% of the portfolio, ranked #740.

D.A. Davidson & Co first reported a position in DXCM in Q2 2015 and has held it in 43 quarters since. The position peaked at $4.92M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • D.A. Davidson & Co held 27,800 shares of DexCom worth $1.75M as of Q1 2026.
  • D.A. Davidson & Co sold 776 DexCom shares in Q1 2026, an estimated $54K.
  • DexCom made up 0.01% of D.A. Davidson & Co's portfolio in Q1 2026, its #740 holding.
  • D.A. Davidson & Co first reported a position in DexCom in Q2 2015 and has held it in 43 quarters since.
  • D.A. Davidson & Co's DexCom position peaked at $4.92M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.